Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

AIMS: We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD). METHODS AND RESULTS: The sildenafil for improving outcomes after valvular correction (SIOVAC) study was a multrice...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermejo, Javier, Yotti, Raquel, García-Orta, Rocío, Sánchez-Fernández, Pedro L, Castaño, Mario, Segovia-Cubero, Javier, Escribano-Subías, Pilar, San Román, José Alberto, Borrás, Xavier, Alonso-Gómez, Angel, Botas, Javier, Crespo-Leiro, María G, Velasco, Sonia, Bayés-Genís, Antoni, López, Amador, Muñoz-Aguilera, Roberto, de Teresa, Eduardo, González-Juanatey, José R, Evangelista, Arturo, Mombiela, Teresa, González-Mansilla, Ana, Elízaga, Jaime, Martín-Moreiras, Javier, González-Santos, José M, Moreno-Escobar, Eduardo, Fernández-Avilés, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905634/
https://www.ncbi.nlm.nih.gov/pubmed/29281101
http://dx.doi.org/10.1093/eurheartj/ehx700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905634/
https://www.ncbi.nlm.nih.gov/pubmed/29281101
http://dx.doi.org/10.1093/eurheartj/ehx700

Ejemplares similares